Diagnostic accuracy of biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants

Research output: Contribution to journalArticlepeer-review

Standard

Harvard

APA

Vancouver

Author

Bibtex

@article{dbc61ae725504537b9b497d0394a2bef,
title = "Diagnostic accuracy of biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants",
abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows:The primary objective of this review is to assess and compare the diagnostic accuracy of ultrasound assessment of fetal growth and placental biomarkers alone and in any combination used after 24 weeks of pregnancy in the identification of placental dysfunction as evidenced by either stillbirth or born small-for-gestational age (SGA). Accuracy is described by the proportion of fetuses who are subsequently stillborn or who have a SGA baby detected by a positive test result (the presence of placental dysfunction) (sensitivity) and by the proportion of fetuses that have an uncomplicated pregnancy following a negative index tests result (absence of placental dysfunction) (specificity).We will investigate the effect of clinical (patient and test characteristics) and methodological factors (study design, threshold used to define SGA) on test performance. The clinical factors include patient group (low-risk or high-risk pregnancies), gestation at measurement, ethnicity, maternal age and method of testing. With regard to methodological variation, studies may include an intervention (delivery or additional fetal surveillance for test positive cases) which will impact on the outcome; therefore we will assess whether this is a source of heterogeneity.",
author = "A Heazell and DJL Hayes and M Whitworth and Yemisi Takwoingi and Susan Bayliss and Clare Davenport",
year = "2016",
doi = "10.1002/14651858.CD012245",
language = "English",
journal = "Cochrane Database of Systematic Reviews",
issn = "1469-493X",
publisher = "Cochrane Collaboration",
number = "6",

}

RIS

TY - JOUR

T1 - Diagnostic accuracy of biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants

AU - Heazell, A

AU - Hayes, DJL

AU - Whitworth, M

AU - Takwoingi, Yemisi

AU - Bayliss, Susan

AU - Davenport, Clare

PY - 2016

Y1 - 2016

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows:The primary objective of this review is to assess and compare the diagnostic accuracy of ultrasound assessment of fetal growth and placental biomarkers alone and in any combination used after 24 weeks of pregnancy in the identification of placental dysfunction as evidenced by either stillbirth or born small-for-gestational age (SGA). Accuracy is described by the proportion of fetuses who are subsequently stillborn or who have a SGA baby detected by a positive test result (the presence of placental dysfunction) (sensitivity) and by the proportion of fetuses that have an uncomplicated pregnancy following a negative index tests result (absence of placental dysfunction) (specificity).We will investigate the effect of clinical (patient and test characteristics) and methodological factors (study design, threshold used to define SGA) on test performance. The clinical factors include patient group (low-risk or high-risk pregnancies), gestation at measurement, ethnicity, maternal age and method of testing. With regard to methodological variation, studies may include an intervention (delivery or additional fetal surveillance for test positive cases) which will impact on the outcome; therefore we will assess whether this is a source of heterogeneity.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows:The primary objective of this review is to assess and compare the diagnostic accuracy of ultrasound assessment of fetal growth and placental biomarkers alone and in any combination used after 24 weeks of pregnancy in the identification of placental dysfunction as evidenced by either stillbirth or born small-for-gestational age (SGA). Accuracy is described by the proportion of fetuses who are subsequently stillborn or who have a SGA baby detected by a positive test result (the presence of placental dysfunction) (sensitivity) and by the proportion of fetuses that have an uncomplicated pregnancy following a negative index tests result (absence of placental dysfunction) (specificity).We will investigate the effect of clinical (patient and test characteristics) and methodological factors (study design, threshold used to define SGA) on test performance. The clinical factors include patient group (low-risk or high-risk pregnancies), gestation at measurement, ethnicity, maternal age and method of testing. With regard to methodological variation, studies may include an intervention (delivery or additional fetal surveillance for test positive cases) which will impact on the outcome; therefore we will assess whether this is a source of heterogeneity.

U2 - 10.1002/14651858.CD012245

DO - 10.1002/14651858.CD012245

M3 - Article

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

IS - 6

M1 - CD012245

ER -